Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
Revatis is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Cardiovascular
Endocrinology
Quick Facts
HQ:Belgium
Founded:2000
Employees:838
Capabilities & Services
Core Capabilities
- Sterile Injectable
- Sterile Fill/Finish
- Fill/Finish (Vials)
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Cartridge / Pen
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Asia-Pacific
International Regulatory
EU GMP Certificates
2
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval ELPHZA
Health Canada · #APR-KH126KD6 · 2022-07-01
Drug Approval XEOGM2
EMA · #APR-CIKLSCCQ · 2020-07-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-YIBJ9P1A
Issued: 2020-12-15
Expires: 2025-04-02
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-QWTANZ4C
Issued: 2020-04-13
Expires: 2025-06-18
Loading CDMO intelligence...
Key facts about Revatis
- Revatis is headquartered in Belgium.
- Revatis was founded in 2000.
- Revatis has 838 employees.
- Revatis's capabilities include Sterile Injectable, Sterile Fill/Finish and Fill/Finish (Vials).
Find CDMOs like Revatis
Directory pages this company appears in, each with the full list of matching manufacturers.